2017/03/01 by Keith Wailoo · 42 citations
Medicine · #Hemoglobinopathies and Related Disorders #Medicine #Disease #Context (archaeology) #Medical history #Intensive care medicine #Psychiatry #Family medicine #Surgery #Pathology #History
paper · doi:10.1056/nejmp1700101
published in New England Journal of Medicine 376(9), 805-807 (Massachusetts Medical Society)
openalex publication_date 2017/03/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Interview with Dr. Keith Wailoo on the medical and social context that has made progress in treating sickle cell disease slow and arduous. (11:31)Download Given sickle cell disease’s prevalence among black Americans, questions of race and stigma have shadowed the history of its medical treatment. Recent developments in treating pain crises and gene therapy are part of a history of slow progress tinged with constant peril.